This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.

Dev

Joined: October 9, 2025
Articles: 6278

survey

Community based assessments regarding vascular contributions to Alzheimers Disease in M2OVE AD consortium

Community based assessments regarding vascular contributions to Alzheimers Disease in M2OVE AD consortium Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Interdisciplinary Research to Understand the Interplay of Diabetes, Cerebrovascular disease and Alzheimers disease

Interdisciplinary Research to Understand the Interplay of Diabetes, Cerebrovascular disease and Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

The IU/JAX Alzheimers Disease Precision Models Center

The IU/JAX Alzheimers Disease Precision Models Center Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Molecular Characterization and Validation of Gender Differences in Alzheimers Disease Pathogenesis

Molecular Characterization and Validation of Gender Differences in Alzheimers Disease Pathogenesis Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Multi-level Integrative Proteomics to Alzheimers Disease Pathways

Multi-level Integrative Proteomics to Alzheimers Disease Pathways Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

RNA binding proteins as novel targets in Alzheimers disease

RNA binding proteins as novel targets in Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD

Preclinical Development of a Selective Suppressor of Neuroinflammation for MCI/AD Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Cholesterol and Sphingolipid Metabolism in Alzheimers Disease

Cholesterol and Sphingolipid Metabolism in Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016

Dev
August 6, 2018

survey

Role of CK2 in NMDAR trafficking during development and in Alzheimers disease

Role of CK2 in NMDAR trafficking during development and in Alzheimers disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016